# Xian-Janssen Pharmaceutical Ltd. clinical trials: 36 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 36 trials with Xian-Janssen Pharmaceutical Ltd. as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Xian-Janssen Pharmaceutical Ltd.: 36 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/xian-janssen-pharmaceutical-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 36
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 36, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| December 30, 2025 | NCT07310095 | A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD) | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Recruiting | Crohn Disease | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07310095) |
| December 24, 2025 | NCT07302360 | A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis | Xian-Janssen Pharmaceutical Ltd. | Observational | Recruiting | Colitis, Ulcerative | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07302360) |
| October 13, 2023 | NCT06082986 | A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China | Xian-Janssen Pharmaceutical Ltd. | Observational | Completed | Crohn Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06082986) |
| August 6, 2018 | NCT03617016 | Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Completed | Dyspepsia | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03617016) |
| July 18, 2017 | NCT03220867 | Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy... | Xian-Janssen Pharmaceutical Ltd. | Phase 1 | Withdrawn | Healthy | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03220867) |
| June 22, 2017 | NCT03196531 | A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With... | Xian-Janssen Pharmaceutical Ltd. | Phase 1 | Completed | Healthy | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03196531) |
| May 12, 2017 | NCT03151720 | A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants... | Xian-Janssen Pharmaceutical Ltd. | Phase 1 | Completed | Healthy | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03151720) |
| February 14, 2017 | NCT03053024 | Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants | Xian-Janssen Pharmaceutical Ltd. | Observational | Completed | Lymphoma, Mantle-Cell | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03053024) |
| September 9, 2016 | NCT02895529 | A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in... | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Terminated | Hematologic Neoplasms | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02895529) |
| January 16, 2015 | NCT02340481 | Efficacy and Safety Study of Loperamide Hydrochloride/Simethicone Chewable Tablet in Treatment of Acute Diarrhea With Abdominal Discomfort... | Xian-Janssen Pharmaceutical Ltd. | Phase 3 | Completed | Diarrhea | 217 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02340481) |
| August 29, 2014 | NCT02228616 | Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic Constipation | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Completed | Constipation | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02228616) |
| September 20, 2013 | NCT01947803 | A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Completed | Schizophrenia | 353 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01947803) |
| September 2, 2013 | NCT01933880 | A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive... | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Completed | Attention Deficit Hyperactivity Disorder (ADHD) | 194 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01933880) |
| August 23, 2013 | NCT01928316 | A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers | Xian-Janssen Pharmaceutical Ltd. | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01928316) |
| July 10, 2013 | NCT01894984 | An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia | Xian-Janssen Pharmaceutical Ltd. | Observational | Terminated | Schizophrenia | 640 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01894984) |
| June 19, 2013 | NCT01881282 | A Comparative Efficacy and Safety Study of Compound Carraghenates Cream With Mayinglong Musk Hemorrhoid Ointment in the Treatment of... | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Completed | Hemorrhoids | 123 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01881282) |
| June 6, 2013 | NCT01870843 | A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With... | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Completed | Depressive Disorder, Major | 261 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01870843) |
| April 30, 2013 | NCT01843660 | An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back... | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Completed | Low Back Pain, Shoulder Pain, Neck Pain | 1,059 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01843660) |
| April 26, 2013 | NCT01840943 | A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line... | Xian-Janssen Pharmaceutical Ltd. | Phase 3 | Terminated | Epithelial Ovarian Cancer | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01840943) |
| April 4, 2013 | NCT01824524 | A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With... | Xian-Janssen Pharmaceutical Ltd. | Phase 1 | Completed | Pain | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01824524) |
| April 4, 2013 | NCT01823289 | An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary... | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Completed | Pulmonary Fungal Infection | 71 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01823289) |
| March 19, 2013 | NCT01814098 | An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Completed | Depressive Disorder, Major | 318 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01814098) |
| March 19, 2013 | NCT01814085 | A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | Completed | Major Depressive Disorder | 225 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01814085) |
| December 18, 2012 | NCT01751867 | An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome | Xian-Janssen Pharmaceutical Ltd. | Phase 3 | Completed | Myelodysplastic Syndrome | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01751867) |
| September 25, 2012 | NCT01692678 | A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma | Xian-Janssen Pharmaceutical Ltd. | Phase 3 | Completed | Advanced or Metastatic Liposarcoma or Leiomyosarcoma | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01692678) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 6 |
| Phase 3 | 11 |
| Phase 4 | 14 |
| Observational | 5 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 30 |
| Terminated | 3 |
| Recruiting | 2 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Schizophrenia | 6 |
| Depressive Disorder, Major | 3 |
| Neoplasms | 3 |
| Crohn Disease | 2 |
| Colitis, Ulcerative | 2 |
| Gastrointestinal Hemorrhage | 1 |
| Inflammatory Bowel Diseases | 1 |
| Alzheimer Disease | 1 |
| Diarrhea | 1 |
| Flatulence | 1 |
| Heart Failure | 1 |
| Lymphoma, Mantle-Cell | 1 |
| Low Back Pain | 1 |
| Shoulder Pain | 1 |
| Neck Pain | 1 |
| Multiple Myeloma | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Carcinoma | 1 |
| Ovarian Neoplasms | 1 |
| Pain | 1 |
| Arthritis, Rheumatoid | 1 |
| Myelodysplastic Syndromes | 1 |
| Hemorrhoids | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Liposarcoma | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Electrical supply stores in the United States](https://specstream.ai/data/businesses/electrical-supply-stores/united-states)
- [Avionics shops in the United States](https://specstream.ai/data/businesses/avionics-shops/united-states)
- [Salvadoran restaurants in the United States](https://specstream.ai/data/businesses/salvadoran-restaurants/united-states)
- [Language schools in the United States](https://specstream.ai/data/businesses/language-schools/united-states)
- [Drama schools in the United States](https://specstream.ai/data/businesses/drama-schools/united-states)
